Lawsuits over AngioDynamics implanted port catheters keep coming. As of November 2, 2026, 450 cases were pending in the federal litigation in San Diego, up from 295 at the start of the year, according to the Judicial Panel on Multidistrict Litigation.
The lawsuits claim that the catheters on AngioDynamics ports, including SmartPort, Vortex, Xcela and BioFlo models, can break down inside the body and cause fractures, infections and blood clots. AngioDynamics and its Navilyst Medical subsidiary deny the claims.
What the Lawsuits Allege
An implanted port sits under the skin of the chest or arm and connects to a thin catheter that runs into a large vein. It gives doctors an easy way to deliver chemotherapy, IV medicines and fluids and to draw blood, often for months or years.
The lawsuits allege that the catheters contain too much barium sulfate, a compound added so the tubing shows up on X-rays, and that this weakens the material over time. Plaintiffs allege the catheter surface can pit and crack, giving bacteria and blood clots a place to form, and that pieces can break off and travel to the heart or lungs. They also allege the companies failed to warn doctors about these risks.
Where the San Diego Litigation Stands
The Judicial Panel on Multidistrict Litigation grouped the federal cases in October 2024 as MDL No. 3125 and assigned them to U.S. District Judge Jinsook Ohta in the Southern District of California. One judge oversees the shared evidence gathering, while each person keeps an individual claim.
The court is now choosing test cases, called bellwethers. On August 4, 2026, each side picked nine cases, creating a pool of 18 that mixes infection, blood clot and catheter fracture claims. The parties are collecting records and taking depositions in those cases, and the pool is to be narrowed after that early discovery, which is expected to run into 2027. No trial date has been set, and lawyers following the litigation do not expect a first trial before 2028.
In its most recent quarterly report, AngioDynamics said that as of August 31, 2026, it was defending about 430 product liability claims involving its port products and could not predict the outcome of the litigation.
Why the Bard PowerPort Trials Matter
A larger group of port catheter lawsuits against C.R. Bard is about two years ahead in federal court in Arizona, with 4,345 cases pending as of November 2. Those cases rest on the same basic theory about the catheter material. Juries sided with Bard on most or all claims in two infection cases, and a jury awarded Kimberly Divelbliss $40 million in a catheter fracture case in September 2026. The first PowerPort blood clot trial is set to begin December 1.
Results in the Bard cases are likely to shape how the AngioDynamics claims are valued well before any of them reach a jury. For more on the Bard litigation, see our Bard PowerPort lawsuit update.
Who May Have a Claim
People who had an AngioDynamics port and later suffered a catheter fracture or migration, a bloodstream infection or a blood clot linked to the device may have a claim for compensation. Many patients do not know which company made their port. The operative report and implant records from the placement procedure usually name the manufacturer and model. Deadlines to file, called statutes of limitations, vary by state and often run from when the injury was discovered.
Doyle APC, based in San Diego, is investigating AngioDynamics port catheter claims nationwide.
Common Questions
What are the AngioDynamics port catheter lawsuits about?
The lawsuits claim that the catheters on AngioDynamics implanted ports can break down inside the body, leading to fractures, migration, bloodstream infections and blood clots, and that AngioDynamics and its Navilyst Medical subsidiary failed to warn doctors. The companies deny the claims.
How many AngioDynamics port lawsuits are pending?
As of November 2, 2026, 450 cases were pending in MDL No. 3125 in the U.S. District Court for the Southern District of California, according to the Judicial Panel on Multidistrict Litigation.
Is there an AngioDynamics port class action?
No. These are individual injury lawsuits grouped in a federal multidistrict litigation, or MDL, so one judge can manage pretrial matters. Each person keeps their own claim.
Has AngioDynamics settled the port catheter lawsuits?
No. As of November 2026, AngioDynamics has not announced a settlement, and no trial date has been set.
Which AngioDynamics ports are involved?
The lawsuits involve implanted ports sold under the SmartPort, Vortex, Xcela and BioFlo names. The operative report and implant records from the placement procedure usually identify the maker and model.
Problems With an Implanted Port?
Doyle APC helps people and families nationwide. You pay nothing unless we recover.
